BioLineRx Announces Closing of $34.5 Million Bought Deal Offering and Full Exercise of the Option of the Underwriter
BioLineRx Increases Previously Announced Bought Deal Offering to $30 Million
BioLineRx Announces $10 Million Bought Deal Offering